Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	168.08B
Revenue (ttm)	137.55B
Net Income (ttm)	17.36B
Shares Out	8.80M
EPS (ttm)	1,766.00
PE Ratio	10.82
Forward PE	n/a
Dividend	2,700.00 (15.88%)
Ex-Dividend Date	Mar 21, 2025

Volume	16,056
Average Volume	7,356
Open	19,000
Previous Close	18,700
Day's Range	19,000 - 20,000
52-Week Range	14,800 - 20,600
Beta	0.07
RSI	67.37
Earnings Date	Apr 18, 2025

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. The ...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2024, HNX:PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 17.36 billion, a decrease of -13.72%.